Enveric Biosciences Inc (ENVB)
0.98
+0.05
(+5.89%)
USD |
NASDAQ |
May 03, 16:00
0.9616
-0.02
(-1.88%)
After-Hours: 20:00
Enveric Biosciences Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| March 31, 2020 | 38.83M |
| December 31, 2019 | 39.91M |
| September 30, 2019 | 41.13M |
| June 30, 2019 | 42.56M |
| March 31, 2019 | 42.62M |
| December 31, 2018 | 43.00M |
| September 30, 2018 | 44.17M |
| June 30, 2018 | 46.12M |
| March 31, 2018 | 47.32M |
| December 31, 2017 | 48.59M |
| September 30, 2017 | 49.53M |
| June 30, 2017 | 47.05M |
| March 31, 2017 | 41.47M |
| December 31, 2016 | 36.15M |
| September 30, 2016 | 28.22M |
| June 30, 2016 | 22.09M |
| March 31, 2016 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 |
| Date | Value |
|---|---|
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 | |
| June 30, 2011 | |
| March 31, 2011 | |
| December 31, 2010 | |
| September 30, 2010 | |
| June 30, 2010 | |
| March 31, 2010 | |
| December 31, 2009 | |
| September 30, 2009 | |
| June 30, 2009 | |
| March 31, 2009 | |
| December 31, 2008 | |
| September 30, 2008 | |
| June 30, 2008 | |
| March 31, 2008 | |
| December 31, 2007 | |
| September 30, 2007 | 0.8228M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
38.83M
Minimum
Mar 2020
42.56M
Maximum
Jun 2019
40.61M
Average
40.52M
Median
Revenue (TTM) Benchmarks
| Seelos Therapeutics Inc | -- |
| Societal CDMO Inc (DELISTED) | 94.64M |
| Cardiff Oncology Inc | 0.488M |
| BioVie Inc | -- |
| Adial Pharmaceuticals Inc | -- |